Prof. Dr. Jan Baumbach will talk about "From systems medicine to COVID-19 - Network-enhanced drug repurposing"
Many scientists in the Hamburg metropolitan area are involved in research related to SARS-CoV-2 and the COVID-19 pandemic. In cooperation with the Helmholtz graduate school for Data Science in Hamburg (DASHH), the Leibniz ScienceCampus InterACt wants to increase the visibility of this research fostering new contacts and potential collaborations. Therefore, the new online Hamburg COVID-19 lecture series started on August 12th. The series represents a unique platform for vivid exchange and takes place every two weeks with a 30-minute lecture and room for further discussions afterwards.
The next lecture will take place on Wednesday, September 23, at 4 pm via zoom. Prof. Dr. Jan Baumbach (TUM) will give us an insight into his corona research.
One major obstacle in current medicine and drug development is inherent in the way we define and approach diseases. In the talk we discuss the prognostic value of (multi-)omics panels. We have a closer look at breast cancer survival and treatment outcome, as case example, using gene expression panels - and we will discuss the current "best practice" in the light of critical statistical considerations. In addition, we introduce computational network and system medicine. We discuss novel developments in graph-based artificial intelligence. Finally, we demonstrate how this concept was very recently applied to drug repurposing to fight SARS-CoV2/COVID-19. We conclude that network medicine and modern AI open new avenues to shape future medicine.
For further information please contact the InterACt office or subscribe to our mailing list using the link https://bit.ly/3grlxxz.